| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.46B | — | +24.4% |
| R&D Expense | $13.0M | — | +0.0% |
| SG&A Expense | $97.0M | — | +24.4% |
| Interest Expense | $28.0M | — | +3.7% |
| Pre-tax Income | $272.0M | — | +338.7% |
| Income Tax | $76.0M | — | +216.7% |
| Net Income | $199.0M | — | +437.8% |
| EPS (Basic) | $1.47 | — | +465.4% |
| EPS (Diluted) | $1.42 | — | +446.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $143.0M | +19.2% | +21.2% |
| Accounts Receivable | $853.0M | +39.6% | +28.3% |
| Inventory | $1.67B | +18.8% | +30.8% |
| Current Assets | $2.95B | +27.1% | +32.0% |
| Total Assets | $5.84B | +9.2% | +13.1% |
| Current Liabilities | $2.12B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $73.0M | — | +25.9% |
| Capital Expenditures | $72.0M | — | +4.3% |
| Investing Cash Flow | -$68.0M | — | -15.3% |
| Financing Cash Flow | $20.0M | — | +176.9% |
| Free Cash Flow | $1.0M | — | +109.1% |
| +17.1% |
| Long-term Debt | $1.94B | +1.7% | +1.6% |
| Total Liabilities | $4.71B | +7.5% | +7.0% |
| Stockholders' Equity | $1.12B | +17.5% | +50.2% |